Aldosterone-to-Renin Ratio as a Marker for Disease Severity in 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
The DOI matches its Crossref record; 36 of the 39 references it cites were found in a registry or an index.
Abstract
CONTEXT: Congenital adrenal hyperplasia (CAH) owing to 21-hydroxylase deficiency (21 OHD) is classified clinically in decreasing order of severity into salt-wasting, simple-virilizing, and nonclassical forms. Causative mutations in the CYP21A2 gene dictate the degrees of adrenal enzyme defect. Salt-wasting crises due to aldosterone deficiency are clinically apparent in the salt-wasting form but not in other forms of 21 OHD. OBJECTIVES: This study examined the ratio of serum aldosterone to plasma renin activity as an index of sodium wasting in patients with 21 OHD CAH, heterozygotes, and normal individuals. DESIGN: This was a cross-sectional, retrospective, noninterventional study. PATIENTS AND OTHER PARTICIPANTS: A total of 402 individuals were included: 224 patients affected with 21 OHD CAH and 178 unaffected subjects. Classification into each diagnostic group was made primarily on the basis of clinical and hormonal features. Affected or unaffected status was confirmed by genotype of CYP21A2. All subjects were on ad lib diets without restrictions. Salt-wasting status was examined by sodium deprivation testing in 32 salt-wasting subjects and 14 simple virilizing subjects. RESULTS: The ratio of serum aldosterone to plasma renin activity was found to discriminate well between the different groups of disease severity. The lowest ratios, indicative of the least sodium conservation, were seen in the salt-wasting group with increasing ratios in the simple virilizing, nonclassical, and unaffected groups. This ratio remained stable with age. CONCLUSION: The ratio of serum aldosterone to plasma renin activity provides a simple index to compare groups of patients with varying degrees of 21 OHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the defect in aldosterone biosynthesis is clinically apparent only in the salt-wasting form, subclinical aldosterone deficiency is present in all forms of 21OHD (184, 185) and is best evaluated by the aldosterone-to-PRA ratio (184).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [184]
Citations
Cites
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Self-citationSpeiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Self-citationCongenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Steroid 21-hydroxylase deficiency: genotype may not predict phenotype
Wilson, R. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.8.2322 · Cited by 324
Self-citationMontori, V. M., & Young, W. F. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00013-0 · Cited by 202
Primary aldosteronism—careful investigation is essential and rewarding
Stowasser, M., & Gordon, R. D. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.006 · Cited by 190
An update of congenital adrenal hyperplasia
NEW, M. I. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1315.009 · Cited by 178
Self-citation
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“clinically apparent only in the salt-wasting form, subclinical aldosterone deficiency is present in all forms of 21OHD (184, 185) and is best evaluated by the aldosterone-to-PRA ratio (184).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Krone, N., Rose, I. T., Willis, D. S., Hodson, J., Wild, S. H., Doherty, E. J., Hahner, S., Parajes, S., Stimson, R. H., Han, T. S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3343 · Cited by 119
“The use of mineralocorticoids in patients with mutation group C can be explained by the fact that even some patient with nonclassic CAH may have subclinical signs of salt loss (24).”
BackgroundManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 106
Riepe, F. G., & Sippell, W. G. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9053-1 · Cited by 107
“produce aldosterone in response to renin stimulation [54].”
BackgroundMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Webb, E. A., & Krone, N. P. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.002 · Cited by 72
“In all forms of CAH a degree and spectrum of aldost erone deficiency and salt-loss is present (27,28).”
BackgroundCongenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Huynh, T., McGown, I. N., Cowley, D. M., Nyunt, O., Leong, G. M., Harris, M. A., & Cotterill, A. M. (2009) · PubMed · Cited by 60
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.
Ambroziak, U., Bednarczuk, T., Ginalska-Malinowska, M., Małunowicz, E., Grzechocińska, B., Kamiński, P., Bablok, L., Przedlacki, J., & Bar‐Andziak, E. (2010) · PubMed · Cited by 49
Silveira, E. L., Santos, Ε. Ρ., Bachega, T. A. S., Nader, I. L., Gross, J. L., & Elnecave, R. H. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.5.455 · Cited by 37
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 40
“Mineralocorticoids Classical SW 21-OHD is not sufficiently treated with HC alone and requires FC (7, 9, 63, 102).”
BackgroundUpdate on adrenal steroid hormone biosynthesis and clinical implications
Bacila, I. A., Elder, C. J., & Krone, N. P. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2017-313873 · Cited by 39
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
“Aldosterone deficiency is clinically evident in the saltwasting form and may occur sub-clinically in the simplevirilizing form (107).”
BackgroundGrowth and Reproductive Outcomes in Congenital Adrenal Hyperplasia
Nebesio, T. D., & Eugster, E. A. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/298937 · Cited by 34
“[57] has shown that there is some degree of aldosterone deficiency present in all forms of 21-hydroxylase deficiency, including simple-virilizing and non-classic forms.”
BackgroundMineralocorticoid Deficiency and Treatment in Congenital Adrenal Hyperplasia
Padidela, R., & Hindmarsh, P. C. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/656925 · Cited by 38
“A degree and spectrum of aldosterone deficiency and salt loss exists in all forms of CAH including those with simple virilising and nonclassical forms of CAH [2, 11, 12].”
BackgroundCongenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency
New, M. I., Lekarev, O., Mancenido, D., Parsa, A. A., & Yuen, T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00003-x · Cited by 28
Self-citationFuture Directions for Adrenal Insufficiency: Cellular Transplantation and Genetic Therapies
Graves, L. E., Torpy, D. J., Coates, P. T., Alexander, I. E., Bornstein, S. R., & Clarke, B. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac751 · Cited by 24
Shetty, V. B., Bower, C., Jones, T. W., Lewis, B. D., & Davis, E. A. (2012) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2012.02584.x · Cited by 17
Matthews, D., & Cheetham, T. D. (2012) · Clinical Endocrinology · doi:10.1111/cen.12065 · Cited by 15
Bizzarri, C., Improda, N., Maggioli, C., Capalbo, D., Roma, S., Porzio, O., Salerno, M., & Cappa, M. (2017) · Endocrine Practice · doi:10.4158/ep171751.or · Cited by 17
Dundar, A., Bayramov, R., Önal, M. G., Akkus, M., Doğan, M. E., Kenanoğlu, S., Güneş, M. C., Kazimli, U., Özbek, M. N., Ercan, O., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04809-4 · Cited by 16
Long-Read Sequencing Solves Complex Structure of CYP21A2 in a Large 21-Hydroxylase Deficiency Cohort
Wang, R., Luo, X., Sun, Y., Liang, L., Mao, A., Lu, D., Zhang, K., Yang, Y., Sun, Y., Sun, M., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae519 · Cited by 16
Management of Infants with Congenital Adrenal Hyperplasia
Dabas, A., Vats, P., Sharma, R., Singh, P., Seth, A., Jain, V., Batra, P., Gupta, N., Kumar, R., Kabra, M., et al. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1735-8 · Cited by 18
Prenatal and Early Postnatal Treatment of Congenital Adrenal Hyperplasia
Ghizzoni, L., Cesari, S., Cremonini, G., & Melandri, L. (2007) · Endocrine development · doi:10.1159/000111058 · Cited by 13
Medical treatment of classic and nonclassic congenital adrenal hyperplasia
Speiser, P. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_9 · Cited by 10
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 13
Kendırcı, H. N. P., Ünal, E., Dündar, İ., Buluş, A. D., Güneş, S. O., & Şıklar, Z. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-26-s · Cited by 11
“Subclinical or overt aldosterone deficiency is present in all forms of classical CAH (25).”
Mineralocorticoid replacement therapy in salt‐wasting congenital adrenal hyperplasia
Lang, K., Quinkler, M. O., & Kienitz, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.14959 · Cited by 9
“54 For mineralocorticoid supplementation in growing individuals fludrocortisone and sodium chloride supplements should be added to the treatment regime.”
Endocrine, cardiac and neuropsychological aspects of adult congenital adrenal hyperplasia
Ridder, L. O. R., Balle, C. M., Skakkebaek, A. H., Lind‐Holst, M., Nielsen, M. M., Hermann, A. P., Hansen, S., Nielsen, D. G., Knorr, S., Andersen, N. H., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.15055 · Cited by 6
21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
Shaw, A. (2010) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.29.3.191 · Cited by 5
Challenges in managing disorders of sex development associated with adrenal dysfunction
Finkielstain, G. P., & Rey, R. A. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2256393 · Cited by 6
“In patients with severe forms, mineralocorticoid treatment is maintained throughout life [7,27,32].”
BackgroundKeeping the pressure on mineralocorticoid replacement in congenital adrenal hyperplasia
Krone, N. P., Webb, E. A., & Hindmarsh, P. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12700 · Cited by 5
Hypothalamic–Pituitary–Adrenal Axis: Congenital Adrenal Hyperplasia
Pasterski, V., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00070-5 · Cited by 5
Characteristics of Patients with Classic Congenital Adrenal Hyperplasia Missed on the Newborn Screen
Saroufim, R., Nebesio, T. D., & Eugster, E. A. (2023) · Hormone Research in Paediatrics · doi:10.1159/000535405 · Cited by 6
Hubska, J., Kępczyńska‐Nyk, A., Czady-Jurszewicz, K., & Ambroziak, U. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020653 · Cited by 8
“However, many people with SV CAH still require mineralocorticoid supplementation early in life and might be classified as SW [15].”
BackgroundGenetic Analysis of Two Japanese Patients with Non-classical 21-Hydroxylase Deficiency
Imamine, R., Arima, H., Kusakabe, M., Umeda, H., Sato, I., Homma, K., Usui, T., & Oiso, Y. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1894 · Cited by 3
“Given that the aldosterone-to-renin ratio could be a marker of 21OHD severity (25), normal (case 2) and increased (case 1) levels of plasma aldosterone as well as the fact that there was no episode of dehydration further suggest that the severity of 21OHD is mild in our cases.”
BackgroundCongenital adrenal hyperplasia owing to 21-hydroxylase deficiency
New, M. I., Lekarev, O., Jacob, M., Macdonald, A., Parsa, A. A., & Yuen, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00031-9 · Cited by 4
Self-citationExploration of the potential of genomic editing in the treatment of congenital adrenal hyperplasia
Graves, L. E., Christina, S., Mullany, K., Alexander, I. E., & Falhammar, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1719376 · Cited by 2
Congenital Adrenal Hyperplasia
Nimkarn, S., & New, M. I. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00015-8 · Cited by 2
Self-citationDisorders of the Adrenal Gland
Fechner, P. Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00096-6 · Cited by 3
Congenital adrenal hyperplasia in adults
Lin‐Su, K., Nimkarn, S., & New, M. I. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.1.67 · Cited by 2
Self-citationDisorders of the Adrenal Gland
Nimkarn, S., & New, M. I. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0134-0.10091-5 · Cited by 3
Self-citationCongenital Adrenal Hyperplasia
Yau, M., Nimkarn, S., & New, M. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00014-2 · Cited by 5
Self-citationPignatelli, D., & Pereira, S. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_2 · Cited by 1
Disorders of the Adrenal Gland
Fechner, P. Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00084-2 · Cited by 1
Clinical practice guidelines "Congenital adrenal hyperplasia in children" with comments
Чугунов, І., Kopylova, I., Kolodkina, A. A., Kalinchenko, N. Y., Vorontsova, M. V., Bezlepkina, O. B., Peterkova, V. A., & Mokrysheva, N. G. (2026) · Problems of Endocrinology · doi:10.14341/probl13767 · Cited by 1
A case of congenital adrenal hyperplasia presenting as adrenal incidentaloma
Choi, M.-J., Kim, B. H., Sohn, K. M., Yang, H. N., Ryu, O. H., Choi, M. G., & Yoo, H. J. (2009) · The Korean Journal of Internal Medicine · Cited by 1
Angiotensinogen gene haplotypes in hypertension
Brugts, J. J., de Maat, M. P. M., den Uil, C. A., & Danser, J. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328311d210
Ionova, T. A., Kolesnikova, G. S., & Калинченко, Н. Ю. (2013) · Problems of Endocrinology · doi:10.14341/probl20135959-15
“В одном исследовании было также продемонстрировано, что АРС у пациентов с ВДКН тесно коррелирует с формой дефицита 21-гидроксилазы и является более специфичным маркером минералокортикоидного дефицита, нежели только АРП [22].”
Nermoen, I. (2013) · NORA - Norwegian Open Research Archives
Hetero sexual precocious puberty: Case report and literature review
Haroon, Z. H., Ijaz, A., Haroon, M. A., Ahmed, S., Pervez, M. A., & Asif, N. (2016) · Case Reports in Internal Medicine · doi:10.5430/crim.v4n1p12
“This helps in differentiating between the salt-wasting and the simple virilizing form of CAH after the newborn period.[15]”
BackgroundAngiotensinogen gene haplotypes in hypertension
Nejatizadeh, A., Stobdan, T., Kumar, R., & Pasha, M. Q. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328314b839
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283040e80
A review on Congenital Adrenal Hyperplasia andits management
Toms, C., Fathima, B., Neethu, R., & Reji, A. (2024) · International Journal of Advanced Research in Biological Sciences (IJARBS) · doi:10.22192/ijarbs.2024.11.06.002 · Cited by 1
Metadata
- Authors
- Nimkarn, S., Lin-Su, K., Berglind, N., Wilson, R. C., & New, M. I.
- Affiliations
- Mount Sinai Hospital (US)
- Department of Pediatrics (S.N., K.L.-S., R.C.W., M.I.N.), Adrenal Steroid Disorders Program, New York, New York 10029
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- New, Maria I.
- ORCID
- Wilson, Robert C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-01-01
- Volume
- 92
- Issue
- 1
- Pages
- 137-142
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2096056009
- Cited by
- 63
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (RR19484, RR‑00071, U54RR019484)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 00072)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- 21-hydroxylase deficiency, congenital adrenal hyperplasia, aldosterone-renin ratio, disease severity classification, salt-wasting crisis, sodium wasting, plasma renin activity, heterozygotes
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Aldosterone, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Infant, Male, Renin, Retrospective Studies, Biomarkers, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.